These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 21876625

  • 1. Hepatitis B virus and hepatocellular carcinoma at the miRNA level.
    Zhang ZZ, Liu X, Wang DQ, Teng MK, Niu LW, Huang AL, Liang Z.
    World J Gastroenterol; 2011 Jul 28; 17(28):3353-8. PubMed ID: 21876625
    [Abstract] [Full Text] [Related]

  • 2. HBX Protein-Induced Downregulation of microRNA-18a is Responsible for Upregulation of Connective Tissue Growth Factor in HBV Infection-Associated Hepatocarcinoma.
    Liu X, Zhang Y, Wang P, Wang H, Su H, Zhou X, Zhang L.
    Med Sci Monit; 2016 Jul 16; 22():2492-500. PubMed ID: 27421245
    [Abstract] [Full Text] [Related]

  • 3. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W, Liu J, Ding B, Chen D, Xu L, Ding J, Jiang D, Zhou L, Zheng S, Fan W.
    J Transl Med; 2019 Jan 03; 17(1):7. PubMed ID: 30602391
    [Abstract] [Full Text] [Related]

  • 4. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS, Su ZR, Lee YP, Liu IT, Yen CJ.
    World J Gastroenterol; 2016 Jun 14; 22(22):5183-92. PubMed ID: 27298561
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.
    Lamontagne J, Steel LF, Bouchard MJ.
    World J Gastroenterol; 2015 Jun 28; 21(24):7375-99. PubMed ID: 26139985
    [Abstract] [Full Text] [Related]

  • 6. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
    Wang Y, Gao Y, Shi W, Zhai D, Rao Q, Jia X, Liu J, Jiao X, Du Z.
    Cancer Biomark; 2015 Jun 28; 15(2):171-80. PubMed ID: 25519019
    [Abstract] [Full Text] [Related]

  • 7. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A, Fujita K, Iwama H, Chiyo T, Fujihara S, Oura K, Tadokoro T, Mimura S, Nomura T, Tani J, Yoneyama H, Kobayashi K, Kamada H, Guan Y, Nishiyama A, Okano K, Suzuki Y, Himoto T, Shimotohno K, Masaki T.
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar 01; 318(3):G401-G409. PubMed ID: 31905024
    [Abstract] [Full Text] [Related]

  • 8. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
    Huang DP, Zeng YH, Yuan WQ, Huang XF, Chen SQ, Wang MY, Qiu YJ, Tong GD.
    Int J Med Sci; 2021 Mar 01; 18(2):335-346. PubMed ID: 33390802
    [Abstract] [Full Text] [Related]

  • 9. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Gao F, Sun X, Wang L, Tang S, Yan C.
    Cell Physiol Biochem; 2015 Mar 01; 37(4):1547-59. PubMed ID: 26512974
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B Virus-Encoded MicroRNA (HBV-miR-3) Regulates Host Gene PPM1A Related to Hepatocellular Carcinoma.
    Chavalit T, Nimsamer P, Sirivassanametha K, Anuntakarun S, Saengchoowong S, Tangkijvanich P, Payungporn S.
    Microrna; 2020 Mar 01; 9(3):232-239. PubMed ID: 31686644
    [Abstract] [Full Text] [Related]

  • 11. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G, Chen X, Chen S, Ye W, Hou K, Liang M.
    J Transl Med; 2016 May 05; 14(1):122. PubMed ID: 27150195
    [Abstract] [Full Text] [Related]

  • 12. Etiologically Significant microRNAs in Hepatitis B Virus-Induced Hepatocellular Carcinoma.
    Ramakrishnan K, Vishwakarma R, Dev RR, Raju R, Rehman N.
    OMICS; 2024 Jun 05; 28(6):280-290. PubMed ID: 38818956
    [Abstract] [Full Text] [Related]

  • 13. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.
    Oncotarget; 2015 Nov 10; 6(35):38093-106. PubMed ID: 26497554
    [Abstract] [Full Text] [Related]

  • 14. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
    Giray BG, Emekdas G, Tezcan S, Ulger M, Serin MS, Sezgin O, Altintas E, Tiftik EN.
    Mol Biol Rep; 2014 Jul 10; 41(7):4513-9. PubMed ID: 24595450
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
    Cheong JY, Shin HD, Cho SW, Kim YJ.
    J Korean Med Sci; 2014 Nov 10; 29(11):1523-7. PubMed ID: 25408584
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
    Pratedrat P, Chuaypen N, Nimsamer P, Payungporn S, Pinjaroen N, Sirichindakul B, Tangkijvanich P.
    PLoS One; 2020 Nov 10; 15(4):e0232211. PubMed ID: 32330203
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression.
    Zhao Q, Li T, Qi J, Liu J, Qin C.
    PLoS One; 2014 Nov 10; 9(10):e109782. PubMed ID: 25299640
    [Abstract] [Full Text] [Related]

  • 20. Dysregulation of miRNA in chronic hepatitis B is associated with hepatocellular carcinoma risk after nucleos(t)ide analogue treatment.
    Wakasugi H, Takahashi H, Niinuma T, Kitajima H, Oikawa R, Matsumoto N, Takeba Y, Otsubo T, Takagi M, Ariizumi Y, Suzuki M, Okuse C, Iwabuchi S, Nakano M, Akutsu N, Kang JH, Matsui T, Yamada N, Sasaki H, Yamamoto E, Kai M, Sasaki Y, Sasaki S, Tanaka Y, Yotsuyanagi H, Tsutsumi T, Yamamoto H, Tokino T, Nakase H, Suzuki H, Itoh F.
    Cancer Lett; 2018 Oct 10; 434():91-100. PubMed ID: 30026054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.